메뉴 건너뛰기




Volumn 33, Issue 28, 2015, Pages 3144-3151

Prediction of allogeneic hematopoietic stem-cell transplantation mortality 100 days after transplantation using a machine learning algorithm: A European group for blood and marrow transplantation acute leukemia working party retrospective data mining study

(20)  Shouval, Roni a,b   Labopin, Myriam c,d,e,f   Bondi, Ori b   Mishan Shamay, Hila a   Shimoni, Avichai a   Ciceri, Fabio g   Esteve, Jordi i   Giebel, Sebastian j   Gorin, Norbert C c   Schmid, Christoph k   Polge, Emmanuelle c   Aljurf, Mahmoud m   Kroger, Nicolaus l   Craddock, Charles n   Bacigalupo, Andrea h   Cornelissen, Jan J o   Baron, Frederic p   Unger, Ron b   Nagler, Arnon a,c   Mohty, Mohamad c,d,e,f  

e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AREA UNDER THE CURVE; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; DATA MINING; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; KARNOFSKY PERFORMANCE STATUS; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; ADVERSE EFFECTS; ALGORITHM; ALLOTRANSPLANTATION; DECISION SUPPORT SYSTEM; DECISION TREE; DISEASE COURSE; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KAPLAN MEIER METHOD; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE; REGISTER; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VALIDATION STUDY;

EID: 84944351165     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.1339     Document Type: Article
Times cited : (117)

References (37)
  • 1
    • 78649429727 scopus 로고    scopus 로고
    • Reduced mortality after allogeneic hematopoieticcell transplantation
    • Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic hematopoieticcell transplantation. N Engl J Med 363: 2091-2101, 2010
    • (2010) N Engl J Med , vol.363 , pp. 2091-2101
    • Gooley, T.A.1    Chien, J.W.2    Pergam, S.A.3
  • 2
    • 77955583042 scopus 로고    scopus 로고
    • How we approach patient evaluation for hematopoietic stem-cell transplantation
    • Hamadani M, Craig M, Awan FT, et al: How we approach patient evaluation for hematopoietic stem-cell transplantation. Bone Marrow Transplantation 45: 1259-1268, 2010
    • (2010) Bone Marrow Transplantation , vol.45 , pp. 1259-1268
    • Hamadani, M.1    Craig, M.2    Awan, F.T.3
  • 3
    • 70350090181 scopus 로고    scopus 로고
    • Risk score for outcome after allogeneic hematopoietic stem-cell transplantation: A retrospective analysis
    • Gratwohl A, Stern M, Brand R, et al: Risk score for outcome after allogeneic hematopoietic stem-cell transplantation: A retrospective analysis. Cancer 115: 4715-4726, 2009
    • (2009) Cancer , vol.115 , pp. 4715-4726
    • Gratwohl, A.1    Stern, M.2    Brand, R.3
  • 4
    • 33645643877 scopus 로고    scopus 로고
    • A risk score for mortality after allogeneic hematopoietic cell transplantation
    • Parimon T, Au DH, Martin PJ, et al: A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144: 407-414, 2006
    • (2006) Ann Intern Med , vol.144 , pp. 407-414
    • Parimon, T.1    Au, D.H.2    Martin, P.J.3
  • 5
    • 23944440464 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT
    • Sorror ML, Maris MB, Storb R, et al: Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 106: 2912-2919, 2005
    • (2005) Blood , vol.106 , pp. 2912-2919
    • Sorror, M.L.1    Maris, M.B.2    Storb, R.3
  • 6
    • 84865261103 scopus 로고    scopus 로고
    • Validation of the hematopoietic cell transplantation-specific comorbidity index: A prospective, multicenter GITMO study
    • Raimondi R, Tosetto A, Oneto R, et al: Validation of the hematopoietic cell transplantation-specific comorbidity index: A prospective, multicenter GITMO study. Blood 120: 1327-1333, 2012
    • (2012) Blood , vol.120 , pp. 1327-1333
    • Raimondi, R.1    Tosetto, A.2    Oneto, R.3
  • 7
    • 84920677167 scopus 로고    scopus 로고
    • Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem-cell transplantation with AML in first complete remission
    • Versluis J, Labopin M, Niederwieser D, et al: Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem-cell transplantation with AML in first complete remission. Leukemia 29: 51-57, 2015
    • (2015) Leukemia , vol.29 , pp. 51-57
    • Versluis, J.1    Labopin, M.2    Niederwieser, D.3
  • 8
    • 84912521796 scopus 로고    scopus 로고
    • Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto study group for cell therapy
    • Nakaya A, Mori T, Tanaka M, et al: Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto study group for cell therapy. Biol Blood Marrow Transplantation 20: 1553-1559, 2014
    • (2014) Biol Blood Marrow Transplantation , vol.20 , pp. 1553-1559
    • Nakaya, A.1    Mori, T.2    Tanaka, M.3
  • 9
    • 84890933391 scopus 로고    scopus 로고
    • Combination of the hematopoietic cell transplantation comorbidity index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-Toxicity allogeneic hematopoietic cell transplantation
    • Barba P, Martino R, Perez-Simon JA, et al: Combination of the hematopoietic cell transplantation comorbidity index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-Toxicity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplantation 20: 66-72, 2014
    • (2014) Biol Blood Marrow Transplantation , vol.20 , pp. 66-72
    • Barba, P.1    Martino, R.2    Perez-Simon, J.A.3
  • 10
    • 84886246781 scopus 로고    scopus 로고
    • The randomized registry trial: The next disruptive technology in clinical research?
    • Lauer MS, D'Agostino RB Sr: The randomized registry trial: The next disruptive technology in clinical research? N Engl J Med 369: 1579-1581, 2013
    • (2013) N Engl J Med , vol.369 , pp. 1579-1581
    • Lauer, M.S.1    D'Agostino, R.B.S.2
  • 11
    • 84904242833 scopus 로고    scopus 로고
    • Application of machine learning algorithms for clinical predictive modeling: A data-mining approach in SCT
    • Shouval R, Bondi O, Mishan H, et al: Application of machine learning algorithms for clinical predictive modeling: A data-mining approach in SCT. Bone Marrow Transplantation 49: 332-337, 2014
    • (2014) Bone Marrow Transplantation , vol.49 , pp. 332-337
    • Shouval, R.1    Bondi, O.2    Mishan, H.3
  • 12
    • 0000245743 scopus 로고    scopus 로고
    • Statistical modeling: The two cultures (with comments and a rejoinder by the author)
    • Breiman L: Statistical modeling: The two cultures (with comments and a rejoinder by the author). Stat Sci 16: 199-231, 2001
    • (2001) Stat Sci , vol.16 , pp. 199-231
    • Breiman, L.1
  • 13
    • 80051660823 scopus 로고    scopus 로고
    • Data mining methods in the prediction of dementia: A real-data comparison of the accuracy sensitivity and specificity of linear discriminant analysis logistic regression neural networks support vector machines classification trees and random forests
    • Maroco J, Silva D, Rodrigues A, et al: Data mining methods in the prediction of dementia: A real-data comparison of the accuracy, sensitivity and specificity of linear discriminant analysis, logistic regression, neural networks, support vector machines, classification trees and random forests. BMC Res Notes 4: 299, 2011
    • (2011) BMC Res Notes , vol.4 , pp. 299
    • Maroco, J.1    Silva, D.2    Rodrigues, A.3
  • 15
    • 0033616908 scopus 로고    scopus 로고
    • Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
    • Gooley TA, Leisenring W, Crowley J, et al: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18: 695-706, 1999
    • (1999) Stat Med , vol.18 , pp. 695-706
    • Gooley, T.A.1    Leisenring, W.2    Crowley, J.3
  • 16
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 17
    • 85018178782 scopus 로고    scopus 로고
    • MED-AB Forms Manual. http://www.ebmt.org/Contents/Data-Management/Registrystructure/MEDABdatacollectionforms/Documents/MED-ABForms Manual.pdf
    • MED-AB Forms Manual.
  • 18
    • 0006452367 scopus 로고    scopus 로고
    • The alternating decision tree learning algorithm
    • Freund Y, Mason L: The alternating decision tree learning algorithm. ICML 99: 124-133, 1999
    • (1999) ICML , vol.99 , pp. 124-133
    • Freund, Y.1    Mason, L.2
  • 19
    • 84856823023 scopus 로고    scopus 로고
    • A new intelligence-based approach for computer-Aided diagnosis of Dengue fever
    • Rao VS, Kumar MN: A new intelligence-based approach for computer-Aided diagnosis of Dengue fever. IEEE Trans Inf Technol Biomed 16: 112-118, 2012
    • (2012) IEEE Trans Inf Technol Biomed , vol.16 , pp. 112-118
    • Rao, V.S.1    Kumar, M.N.2
  • 20
    • 84862207098 scopus 로고    scopus 로고
    • Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
    • Takada M, Sugimoto M, Naito Y, et al: Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model. BMC Med Inform Decis Mak 12: 54, 2012
    • (2012) BMC Med Inform Decis Mak , vol.12 , pp. 54
    • Takada, M.1    Sugimoto, M.2    Naito, Y.3
  • 21
    • 84868209381 scopus 로고    scopus 로고
    • Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
    • Takada M, Sugimoto M, Ohno S, et al: Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique. Breast Cancer Res Treat 134: 661-670, 2012
    • (2012) Breast Cancer Res Treat , vol.134 , pp. 661-670
    • Takada, M.1    Sugimoto, M.2    Ohno, S.3
  • 22
    • 0002345034 scopus 로고
    • The comparison and evaluation of forecasters
    • DeGroot MH, Fienberg SE: The comparison and evaluation of forecasters. Statistician 32: 12-22, 1983
    • (1983) Statistician , vol.32 , pp. 12-22
    • DeGroot, M.H.1    Fienberg, S.E.2
  • 23
    • 67650045441 scopus 로고    scopus 로고
    • Prognosis and prognostic research: Developing a prognostic model
    • Royston P, Moons KG, Altman DG, et al: Prognosis and prognostic research: Developing a prognostic model. BMJ 338: B604, 2009
    • (2009) BMJ , vol.338 , pp. b604
    • Royston, P.1    Moons, K.G.2    Altman, D.G.3
  • 24
    • 84897040330 scopus 로고    scopus 로고
    • Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
    • Blanche P, Dartigues JF, Jacqmin-Gadda H: Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32: 5381-5397, 2013
    • (2013) Stat Med , vol.32 , pp. 5381-5397
    • Blanche, P.1    Dartigues, J.F.2    Jacqmin-Gadda, H.3
  • 25
    • 84867099700 scopus 로고    scopus 로고
    • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: An integrated-risk adapted approach
    • Cornelissen JJ, Gratwohl A, Schlenk RF, et al: The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: An integrated-risk adapted approach. Nat Rev Clin Oncol 9: 579-590, 2012
    • (2012) Nat Rev Clin Oncol , vol.9 , pp. 579-590
    • Cornelissen, J.J.1    Gratwohl, A.2    Schlenk, R.F.3
  • 26
    • 31444444950 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: The role of dose intensity
    • Shimoni A, Hardan I, Shem-Tov N, et al: Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: The role of dose intensity. Leukemia 20: 322-328, 2006
    • (2006) Leukemia , vol.20 , pp. 322-328
    • Shimoni, A.1    Hardan, I.2    Shem-Tov, N.3
  • 27
    • 42449142954 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
    • Sorror M, Storer B, Sandmaier BM, et al: Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer 112: 1992-2001, 2008
    • (2008) Cancer , vol.112 , pp. 1992-2001
    • Sorror, M.1    Storer, B.2    Sandmaier, B.M.3
  • 28
    • 18144443498 scopus 로고    scopus 로고
    • Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation: Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia
    • Frassoni F, Labopin M, Powles R, et al: Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation: Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Lancet 355: 1393-1398, 2000
    • (2000) Lancet , vol.355 , pp. 1393-1398
    • Frassoni, F.1    Labopin, M.2    Powles, R.3
  • 29
    • 84873446375 scopus 로고    scopus 로고
    • The impact of center experience on results of reduced intensity: Allogeneic hematopoietic SCT for AML-An analysis from the Acute Leukemia Working Party of the EBMT
    • Giebel S, Labopin M, Mohty M, et al: The impact of center experience on results of reduced intensity: Allogeneic hematopoietic SCT for AML-An analysis from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation 48: 238-242, 2012
    • (2012) Bone Marrow Transplantation , vol.48 , pp. 238-242
    • Giebel, S.1    Labopin, M.2    Mohty, M.3
  • 30
    • 79956294709 scopus 로고    scopus 로고
    • Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation
    • Gratwohl A, Brand R, Niederwieser D, et al: Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol 29: 1980-1986, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 1980-1986
    • Gratwohl, A.1    Brand, R.2    Niederwieser, D.3
  • 31
    • 27244434337 scopus 로고    scopus 로고
    • Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
    • Corradini P, Zallio F, Mariotti J, et al: Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. J Clin Oncol 23: 6690-6698, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 6690-6698
    • Corradini, P.1    Zallio, F.2    Mariotti, J.3
  • 32
    • 34347391058 scopus 로고    scopus 로고
    • Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem-cell transplantation for acute myeloid leukemia in first or second complete remission
    • Tallman MS, Dewald GW, Gandham S, et al: Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem-cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 110: 409-417, 2007
    • (2007) Blood , vol.110 , pp. 409-417
    • Tallman, M.S.1    Dewald, G.W.2    Gandham, S.3
  • 34
    • 79957958325 scopus 로고    scopus 로고
    • Long-Term survival and late deaths after allogeneic hematopoietic cell transplantation
    • Wingard JR, Majhail NS, Brazauskas R, et al: Long-Term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 29: 2230-2239, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 2230-2239
    • Wingard, J.R.1    Majhail, N.S.2    Brazauskas, R.3
  • 35
    • 63549089131 scopus 로고    scopus 로고
    • Boosting for high-dimensional time-To-event data with competing risks
    • Binder H, Allignol A, Schumacher M, et al: Boosting for high-dimensional time-To-event data with competing risks. Bioinformatics 25: 890-896, 2009
    • (2009) Bioinformatics , vol.25 , pp. 890-896
    • Binder, H.1    Allignol, A.2    Schumacher, M.3
  • 36
    • 84880036844 scopus 로고    scopus 로고
    • A random forest approach for competing risks based on pseudovalues
    • Mogensen UB, Gerds TA: A random forest approach for competing risks based on pseudovalues. Stat Med 32: 3102-3114, 2013
    • (2013) Stat Med , vol.32 , pp. 3102-3114
    • Mogensen, U.B.1    Gerds, T.A.2
  • 37
    • 0032945115 scopus 로고    scopus 로고
    • Retrospective analyses of large medical databases: What do they tell us?
    • Ward RA, Brier ME: Retrospective analyses of large medical databases: What do they tell us? J Am Soc Nephrol 10: 429-432, 1999
    • (1999) J Am Soc Nephrol , vol.10 , pp. 429-432
    • Ward, R.A.1    Brier, M.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.